Developer docs
API playgroundTry for free, no card

Search company profiles

Amplitude Surgical

Full company profile

uuid0027ow6

Namestring
Amplitude Surgical
Legal namestring
AMPLITUDE SAS
Company typeenum
Private
Founded yearint
1997
Descriptiontext

Amplitude Surgical is a French medical device company founded in 1997 in Valence, specializing in surgical technologies for lower-limb orthopaedics, primarily hip and knee replacement procedures. The company's product portfolio spans acetabular cups and femoral stems for total hip arthroplasty (SATURNE II, EVOK, INTEGRALE, ACOR), total and unicompartmental knee prostheses (SCORE II, ANATOMIC, TRAX CR, UNI SCORE), the Andy orthopaedic surgical robot (CE mark approved November 2025), the AMPLIVISION computer-assisted surgery navigation platform, the i.M.A.G.E. patient-specific instrumentation system, sports medicine devices (COMETE), and AMPLIFIX bone cements. Manufacturing occurs at facilities in Valence and Etoile in the Rhône Valley, with clinical validation through surgeon collaboration.

The company sells to orthopaedic surgeons, hospitals, and surgical centers across 33 countries through a direct sales force and exclusive distributor network. Direct business represents approximately 93% of total sales. France is the home market, accounting for 73% of revenue, while international operations are managed through wholly-owned subsidiaries in Australia, Benelux, Brazil, Germany, South Africa, and Switzerland. R&D investment stands at 4.6% of turnover, with 58 R&D engineers among 429 total employees. R&D output is clinically validated, notably the SCORE II femoral component designed from a digitized study of 1,200 knees using AMPLIVISION navigation.

On October 9, 2025, Zydus MedTech (France) SAS, a subsidiary of Indian pharmaceutical group Zydus Lifesciences Limited, completed a simplified tender offer taking Amplitude Surgical private. FY 2024-25 consolidated revenue was €110.8 million, up 5.7% at constant exchange rates, with EBITDA margin of approximately 27%. Revenue is generated primarily through one-time hardware sales of implants and associated instruments, with contract-based B2B medical device pricing. The company has continued expanding its commercial footprint, acquiring France-based FBC Medical in April 2026 to internalize sales capabilities, and entered robotic-assisted surgery commercialization following the Andy robot's first European clinical use in February 2026.

Short descriptiontext

Amplitude Surgical is a French medical device company, founded in 1997 and now under Zydus Lifesciences ownership, that designs and manufactures hip and knee orthopaedic implants, the Andy surgical robot, and AMPLIVISION computer-assisted surgery systems, selling to hospitals and surgeons in 33 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersValence, France
HQ citystring
Valence
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices8 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
orthopaedic implants, lower limb surgery, hip replacement devices, knee prosthesis, surgical robotics
Industry4 codes
PRIMARYHLAHAEAA
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAKALAH
Hip & Knee Reconstruction (Arthroplasty)
SECONDARYHLAHAEAJ
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
NAICS code3 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Orthopaedic Medical Devices
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Orthopaedic Implants and Surgical Products
TypeHardware Sales
Description

Sale of orthopaedic implants (hip and knee prostheses), surgical instruments, computer-assisted surgery systems, and the Andy surgical robot. Revenue model is primarily one-time hardware sales with associated instruments and consumables. FY 2024-25 revenue of €110.8 million, up 5.7% at constant exchange rates.

businesswire.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Orthopaedic implants and surgical systems
ModelOtherBilling cadenceMulti-year contract
Notes

B2B medical device sales with contract-based pricing. No public pricing available.

amplitude-ortho.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 13 records shown
1Andy
Description

Orthopaedic surgical robot designed for precision in bone resections

amplitude-ortho.com
+12 more records
Core offering1 text field

Amplitude Surgical designs, manufactures, and distributes orthopaedic implants and surgical technology for lower-limb procedures (hip and knee). Its portfolio includes acetabular cups, femoral stems, total and unicompartmental knee prostheses, bone cements, ligament repair devices, the AMPLIVISION computer-assisted surgery navigation system, the i.M.A.G.E. patient-specific instrumentation system, and the Andy orthopaedic surgical robot for precision bone resection.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Approximately 27% EBITDA margin for FY 2024-25
+2 more records
Product overview1 text field

Amplitude Surgical is a French medical device company specializing in surgical technologies for lower-limb orthopaedics. Founded in 1997 in Valence, France, the company operates as a unified product portfolio covering hip and knee implants, surgical robots, and computer-assisted surgery systems. The product ecosystem includes: acetabular cups and femoral stems (SATURNE II, EVOK, INTEGRALE, ACOR) for hip replacement; total and unicompartmental knee prostheses (SCORE II, ANATOMIC, TRAX CR) for knee replacement; the Andy robotic surgical system for precision bone resection; the AMPLIVISION computer-assisted surgery navigation platform and i.M.A.G.E. patient-specific instrumentation system; sports medicine products (COMETE, ACLip) for ligament repair; and AMPLIFIX bone cements. Products are designed in Valence with clinical validation, manufactured at production sites in Valence and Etoile in the Rhône Valley, and distributed through direct sales representatives and exclusive distributors across 33+ countries.

Product and service16 records
1SATURNE II
CategoryHip implant
Description

Cementless cylindrico-spherical dual mobility acetabular cup used in total hip arthroplasty. The liner moves within the metal cup and the femoral head moves within the liner, increasing joint stability and reducing wear. CE2797 certified.

2SCORE II
CategoryKnee implant
Description

Primary total knee arthroplasty implant with rotating platform mobile bearing and PCL-sacrificing design. Femoral component design based on study of 1,200 knees digitized using the AMPLIVISION navigation system.

3TRAX CR
CategoryKnee implant
Description

Primary total knee prosthesis with fixed bearing and cruciate-retaining design. Features anatomical lateralized trochlear groove, single radius design, and AXPe vitamin E enriched polyethylene articulating surfaces.

4Andy
CategorySurgical robot
Description

Orthopaedic surgical robot designed for precision in bone resections during lower-limb surgery. Aims to improve surgical outcomes and recovery times for orthopaedic procedures.

5AMPLIVISION
CategoryComputer Assisted Surgery
Description

Computer Assisted Surgery (CAS) navigation system providing navigation-assisted surgery capabilities for improved implant placement accuracy in hip and knee procedures. CE marked.

6i.M.A.G.E.
CategoryPatient-specific instrumentation
Description

Patient-specific instrumentation system for knee replacement surgery, used with or without AMPLIVISION navigation for personalized surgical approaches.

7EVOK
CategoryHip implant
Description

Range of cementless femoral stems available in Standard, Lateralized, and High Offset options. Features quadrangular cross-section with press-fit coating and proximal/distal grooves for higher bone contact.

8STELLAR
CategoryHip implant
Description

Cementless acetabular cup with dimensional press-fit. Compatible with BIOLOX Delta ceramic liner or polyethylene liner. Features up to 4 holes for additional cortical fixation screws.

9ACOR monobloc
CategoryHip implant
Description

Primary anatomical femoral stem available in cemented and cementless versions in Standard and Lateralized models. Features an anatomic 8° metaphyseal curvature matching the proximal femur's natural curvature.

10INTEGRALE
CategoryHip implant
Description

Primary straight femoral stem with full hydroxyapatite (HAP) coating, ovoid metaphyseal cross-section for primary stability, and 137° neck-shaft angle.

11ANATOMIC
CategoryKnee implant
Description

Primary total knee arthroplasty implant matching bone morphology, posterior stabilized, fixed bearing, PCL-sacrificing design. Features trochlear groove angled 6° with constant radius of curvature.

12SCORE
CategoryKnee implant
Description

Primary total knee arthroplasty implant with stability through congruency and rotating platform mobile bearing design. Can be used with or without AMPLIVISION navigation.

13UNI SCORE
CategoryKnee implant
Description

Unicompartmental knee prosthesis used to replace part of the joint surface of the femur and tibia in partial knee replacement procedures.

14AMPLIFIX
CategorySurgical cement
Description

Bone cement product line for implant fixation. Includes AMPLIFIX 1 (standard viscosity) and AMPLIFIX 3 with Gentamicin (low viscosity with antibiotic).

15COMETE Control
CategorySports medicine
Description

Adjustable cortical fixation device for ligament repair with pull-out strength of 1844 N. Features loop length adjustment and locking mechanism for graft fixation.

16CliniRecord
CategoryClinical software
Description

Clinical follow-up platform for patient outcome tracking and post-surgical monitoring.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1FBC Medical
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-04-30
Description

Amplitude Surgical acquired 100% share capital of France-based FBC Medical for €700,000. FBC Medical had operated as a sales agent under exclusive agreement with Amplitude Surgical across multiple French departments. Acquisition internalizes commercial capabilities previously outsourced to third-party sales agents.

manufacturing.economictimes.indiatimes.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-04-27
Description

Long-term partnership between French MedTech companies eCential Robotics and Amplitude Surgical to enhance knee surgery robotics. Companies joined forces to combine expertise in surgical robotics and orthopaedic implants.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

European-focused orthopaedic implant company with hip and knee product lines, similar in scale and geographic focus to Amplitude and acquired by various PE-backed owners historically.

TypeBroad incumbent
Description

Diversified MedTech giant whose DePuy Synthes orthopaedics division competes in hip/knee reconstruction and with the VELYS robotic-assisted surgery platform.

TypeBroad incumbent
Description

Global orthopaedic leader and Amplitude's most direct competitor in robotics through the Mako SmartRobotics platform for hip and knee arthroplasty, which dwarfs Andy's installed base and clinical evidence.

TypeBroad incumbent
Description

Orthopaedic and sports-medicine major that competes with Amplitude in hip/knee implants and with the CORI and ROSA robotics platforms, with a much larger international commercial footprint.

TypeEmerging player
Description

Patient-specific knee implant maker whose iTotal/iUni custom instrumentation approach competes conceptually with Amplitude's i.M.A.G.E. patient-specific guides system.

TypeDirect peer
Description

UK-headquartered orthopaedic implant specialist with hip and knee portfolios and an emphasis on personalised, surgeon-collaborative product design, mirroring Amplitude's go-to-market and innovation philosophy.

TypeBroad incumbent
Description

One of the largest pure-play orthopaedic device companies, competing head-to-head with Amplitude across hip and knee implants and the ROSA Knee robotics system.

8Exactech
TypeDirect peer
Description

US-based orthopaedic implant and instrumentation specialist focused on hip and knee arthroplasty, comparable in product portfolio breadth though larger in US distribution.

TypeBroad incumbent
Description

German MedTech group offering orthopaedic hip and knee implants and surgical instruments in Europe; a long-standing competitor in French and German hospitals where Amplitude also has direct subsidiaries.

TypeDirect peer
Description

Swiss orthopaedic specialist with comparable focus on hip and knee implants, patient-matched instrumentation (MyKnee), and the NextAR minimally invasive surgical navigation platform — closely aligned business model and European footprint.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries7 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Amplitude Surgical

Orthopaedic Medical Devicesamplitude-ortho.com

Amplitude Surgical is a French medical device company, founded in 1997 and now under Zydus Lifesciences ownership, that designs and manufactures hip and knee orthopaedic implants, the Andy surgical robot, and AMPLIVISION computer-assisted surgery systems, selling to hospitals and surgeons in 33 countries.

What Amplitude Surgical does

Amplitude Surgical is a French medical device company founded in 1997 in Valence, specializing in surgical technologies for lower-limb orthopaedics, primarily hip and knee replacement procedures. The company's product portfolio spans acetabular cups and femoral stems for total hip arthroplasty (SATURNE II, EVOK, INTEGRALE, ACOR), total and unicompartmental knee prostheses (SCORE II, ANATOMIC, TRAX CR, UNI SCORE), the Andy orthopaedic surgical robot (CE mark approved November 2025), the AMPLIVISION computer-assisted surgery navigation platform, the i.M.A.G.E. patient-specific instrumentation system, sports medicine devices (COMETE), and AMPLIFIX bone cements. Manufacturing occurs at facilities in Valence and Etoile in the Rhône Valley, with clinical validation through surgeon collaboration.

The company sells to orthopaedic surgeons, hospitals, and surgical centers across 33 countries through a direct sales force and exclusive distributor network. Direct business represents approximately 93% of total sales. France is the home market, accounting for 73% of revenue, while international operations are managed through wholly-owned subsidiaries in Australia, Benelux, Brazil, Germany, South Africa, and Switzerland. R&D investment stands at 4.6% of turnover, with 58 R&D engineers among 429 total employees. R&D output is clinically validated, notably the SCORE II femoral component designed from a digitized study of 1,200 knees using AMPLIVISION navigation.

On October 9, 2025, Zydus MedTech (France) SAS, a subsidiary of Indian pharmaceutical group Zydus Lifesciences Limited, completed a simplified tender offer taking Amplitude Surgical private. FY 2024-25 consolidated revenue was €110.8 million, up 5.7% at constant exchange rates, with EBITDA margin of approximately 27%. Revenue is generated primarily through one-time hardware sales of implants and associated instruments, with contract-based B2B medical device pricing. The company has continued expanding its commercial footprint, acquiring France-based FBC Medical in April 2026 to internalize sales capabilities, and entered robotic-assisted surgery commercialization following the Andy robot's first European clinical use in February 2026.

Amplitude Surgical firmographics

Firmographics
Name
Amplitude Surgical
Legal name
AMPLITUDE SAS
Website
https://amplitude-ortho.com
Company type
Private
Founded year
1997
Operating status
Operating
Headcount range
251–500 employees
Short description
Amplitude Surgical is a French medical device company, founded in 1997 and now under Zydus Lifesciences ownership, that designs and manufactures hip and knee orthopaedic implants, the Andy surgical robot, and AMPLIVISION computer-assisted surgery systems, selling to hospitals and surgeons in 33 countries.
Ownership category
akta.pro rank

Amplitude Surgical industry classification

Industry
Product category
Orthopaedic Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAEAA
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAKALAH
Hip & Knee Reconstruction (Arthroplasty)
SECONDARYHLAHAEAJ
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)

Keywords

  • Orthopaedic implants
  • Lower limb surgery
  • Hip replacement devices
  • Knee prosthesis
  • Surgical robotics

Where Amplitude Surgical is headquartered

Location

Headquarters

HQ city
Valence
HQ country
France
HQ region
Europe

Offices8 records

Markets served

Amplitude Surgical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Orthopaedic Implants and Surgical Products: Sale of orthopaedic implants (hip and knee prostheses), surgical instruments, computer-assisted surgery systems, and the Andy surgical robot. Revenue model is primarily one-time hardware sales with associated instruments and consumables. FY 2024-25 revenue of €110.8 million, up 5.7% at constant exchange rates.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractOrthopaedic implants and surgical systems

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Amplitude Surgical product offering

Product offering

Core offering

Amplitude Surgical designs, manufactures, and distributes orthopaedic implants and surgical technology for lower-limb procedures (hip and knee). Its portfolio includes acetabular cups, femoral stems, total and unicompartmental knee prostheses, bone cements, ligament repair devices, the AMPLIVISION computer-assisted surgery navigation system, the i.M.A.G.E. patient-specific instrumentation system, and the Andy orthopaedic surgical robot for precision bone resection.

Product overview

Amplitude Surgical is a French medical device company specializing in surgical technologies for lower-limb orthopaedics. Founded in 1997 in Valence, France, the company operates as a unified product portfolio covering hip and knee implants, surgical robots, and computer-assisted surgery systems. The product ecosystem includes: acetabular cups and femoral stems (SATURNE II, EVOK, INTEGRALE, ACOR) for hip replacement; total and unicompartmental knee prostheses (SCORE II, ANATOMIC, TRAX CR) for knee replacement; the Andy robotic surgical system for precision bone resection; the AMPLIVISION computer-assisted surgery navigation platform and i.M.A.G.E. patient-specific instrumentation system; sports medicine products (COMETE, ACLip) for ligament repair; and AMPLIFIX bone cements. Products are designed in Valence with clinical validation, manufactured at production sites in Valence and Etoile in the Rhône Valley, and distributed through direct sales representatives and exclusive distributors across 33+ countries.

Differentiator

Problem solved

Functional benefit

Brands

  • Andy: Orthopaedic surgical robot designed for precision in bone resections
  • AMPLIVISION
  • i.M.A.G.E.
  • AMPLIFIX
  • COMETE
  • E.T.O.I.L.E.
  • SATURNE
  • SCORE
  • EVOK
  • ACOR
  • TRAX
  • STELLAR
  • HORIZON

Products and services

  • SATURNE II Cementless cylindrico-spherical dual mobility acetabular cup used in total hip arthroplasty. The liner moves within the metal cup and the femoral head moves within the liner, increasing joint stability and reducing wear. CE2797 certified.
  • SCORE II Primary total knee arthroplasty implant with rotating platform mobile bearing and PCL-sacrificing design. Femoral component design based on study of 1,200 knees digitized using the AMPLIVISION navigation system.
  • TRAX CR Primary total knee prosthesis with fixed bearing and cruciate-retaining design. Features anatomical lateralized trochlear groove, single radius design, and AXPe vitamin E enriched polyethylene articulating surfaces.
  • Andy Orthopaedic surgical robot designed for precision in bone resections during lower-limb surgery. Aims to improve surgical outcomes and recovery times for orthopaedic procedures.
  • AMPLIVISION Computer Assisted Surgery (CAS) navigation system providing navigation-assisted surgery capabilities for improved implant placement accuracy in hip and knee procedures. CE marked.
  • i.M.A.G.E. Patient-specific instrumentation system for knee replacement surgery, used with or without AMPLIVISION navigation for personalized surgical approaches.
  • EVOK Range of cementless femoral stems available in Standard, Lateralized, and High Offset options. Features quadrangular cross-section with press-fit coating and proximal/distal grooves for higher bone contact.
  • STELLAR Cementless acetabular cup with dimensional press-fit. Compatible with BIOLOX Delta ceramic liner or polyethylene liner. Features up to 4 holes for additional cortical fixation screws.
  • ACOR monobloc Primary anatomical femoral stem available in cemented and cementless versions in Standard and Lateralized models. Features an anatomic 8° metaphyseal curvature matching the proximal femur's natural curvature.
  • INTEGRALE Primary straight femoral stem with full hydroxyapatite (HAP) coating, ovoid metaphyseal cross-section for primary stability, and 137° neck-shaft angle.
  • ANATOMIC Primary total knee arthroplasty implant matching bone morphology, posterior stabilized, fixed bearing, PCL-sacrificing design. Features trochlear groove angled 6° with constant radius of curvature.
  • SCORE Primary total knee arthroplasty implant with stability through congruency and rotating platform mobile bearing design. Can be used with or without AMPLIVISION navigation.
  • UNI SCORE Unicompartmental knee prosthesis used to replace part of the joint surface of the femur and tibia in partial knee replacement procedures.
  • AMPLIFIX Bone cement product line for implant fixation. Includes AMPLIFIX 1 (standard viscosity) and AMPLIFIX 3 with Gentamicin (low viscosity with antibiotic).
  • COMETE Control Adjustable cortical fixation device for ligament repair with pull-out strength of 1844 N. Features loop length adjustment and locking mechanism for graft fixation.
  • CliniRecord Clinical follow-up platform for patient outcome tracking and post-surgical monitoring.

Quantifiable outcome

  • Approximately 27% EBITDA margin for FY 2024-25
  • +2 more outcomes

Companies that use Amplitude Surgical

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles1 record

Amplitude Surgical technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Amplitude Surgical partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered minor and core.

  • FBC MedicalminorStrategic or Co-development Partner · 30 April 2026Amplitude Surgical acquired 100% share capital of France-based FBC Medical for €700,000. FBC Medical had operated as a sales agent under exclusive agreement with Amplitude Surgical across multiple French departments. Acquisition internalizes commercial capabilities previously outsourced to third-party sales agents.
  • eCential RoboticscoreStrategic or Co-development Partner · 27 April 2022Long-term partnership between French MedTech companies eCential Robotics and Amplitude Surgical to enhance knee surgery robotics. Companies joined forces to combine expertise in surgical robotics and orthopaedic implants.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Amplitude Surgical competitors and assessment

Company assessment

Direct peers

  • Mathys (Mathys European Orthopaedics): European-focused orthopaedic implant company with hip and knee product lines, similar in scale and geographic focus to Amplitude and acquired by various PE-backed owners historically.
  • Corin: UK-headquartered orthopaedic implant specialist with hip and knee portfolios and an emphasis on personalised, surgeon-collaborative product design, mirroring Amplitude's go-to-market and innovation philosophy.
  • Exactech: US-based orthopaedic implant and instrumentation specialist focused on hip and knee arthroplasty, comparable in product portfolio breadth though larger in US distribution.
  • Medacta International: Swiss orthopaedic specialist with comparable focus on hip and knee implants, patient-matched instrumentation (MyKnee), and the NextAR minimally invasive surgical navigation platform — closely aligned business model and European footprint.

Broad incumbents

  • Johnson & Johnson MedTech (DePuy Synthes): Diversified MedTech giant whose DePuy Synthes orthopaedics division competes in hip/knee reconstruction and with the VELYS robotic-assisted surgery platform.
  • Stryker: Global orthopaedic leader and Amplitude's most direct competitor in robotics through the Mako SmartRobotics platform for hip and knee arthroplasty, which dwarfs Andy's installed base and clinical evidence.
  • Smith+Nephew: Orthopaedic and sports-medicine major that competes with Amplitude in hip/knee implants and with the CORI and ROSA robotics platforms, with a much larger international commercial footprint.
  • Zimmer Biomet: One of the largest pure-play orthopaedic device companies, competing head-to-head with Amplitude across hip and knee implants and the ROSA Knee robotics system.
  • B. Braun / Aesculap: German MedTech group offering orthopaedic hip and knee implants and surgical instruments in Europe; a long-standing competitor in French and German hospitals where Amplitude also has direct subsidiaries.

Emerging players

  • Conformis: Patient-specific knee implant maker whose iTotal/iUni custom instrumentation approach competes conceptually with Amplitude's i.M.A.G.E. patient-specific guides system.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Amplitude Surgical social profiles

Digital presence

Amplitude Surgical compliance and trust

Trust signal

Compliance1 record

Amplitude Surgical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Amplitude Surgical leadership team

Management profile

Number of profiles

Profiles1 record

Amplitude Surgical subsidiaries and ownership

Company hierarchy

Subsidiaries7 records

Amplitude Surgical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Amplitude Surgical M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amplitude Surgical

What does Amplitude Surgical do?

Amplitude Surgical designs, manufactures, and distributes orthopaedic implants and surgical technology for lower-limb procedures (hip and knee). Its portfolio includes acetabular cups, femoral stems, total and unicompartmental knee prostheses, bone cements, ligament repair devices, the AMPLIVISION computer-assisted surgery navigation system, the i.M.A.G.E. patient-specific instrumentation system, and the Andy orthopaedic surgical robot for precision bone resection.

Is Amplitude Surgical a public or private company?

Amplitude Surgical is a private company. It is classified as corporate owned and is currently operating.

When was Amplitude Surgical founded?

Amplitude Surgical was founded in 1997. It employs 251 to 500 people.

Where is Amplitude Surgical based?

Amplitude Surgical is headquartered in Valence, France, in the Europe region.

How does Amplitude Surgical make money?

One revenue line is on record: orthopaedic Implants and Surgical Products.

Who are Amplitude Surgical's main competitors?

Direct peers on record are Mathys (Mathys European Orthopaedics), Corin, Exactech and Medacta International. Broad incumbents are Johnson & Johnson MedTech (DePuy Synthes), Stryker, Smith+Nephew, Zimmer Biomet and B. Braun / Aesculap. Conformis is listed as an emerging player.

Does Amplitude Surgical have an API?

No public API is recorded for Amplitude Surgical.

What industry is Amplitude Surgical in?

Amplitude Surgical's product category is Orthopaedic Medical Devices. Its primary akta.pro industry code is HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle), with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ScanXZydus reports 36% renewable energy in FY26 BRSRZydus Lifesciences released its FY2025-26 Integrated Annual Report reporting highest-ever consolidated revenue of ₹271.5 billion, representing a 17% year-on-year increase, with EBITDA of ₹84,751 million (up 20%) and adjusted PAT of ₹54,564 million (up 15%). The company completed transformative acquisitions including Amplitude Surgical SA (France), Agenus biologics facilities (USA), and Comfort Click Limited (UK), while achieving R&D milestones such as USFDA NDA filing for Saroglitazar and approval of Zycubo for Menkes disease.bne IntelliNewsIndia as a rising pharmaceutical powerIndia has become the world's third-largest pharmaceutical producer by volume, with over 3,000 companies and 10,500 manufacturing facilities. Its exports reached $30.5bn in FY2024-25, a 16-fold increase from FY2000-21, and the domestic market is valued at $60bn, potentially reaching $130bn by 2030.India's most comprehensive portal on pharmaceutical NewsIndian pharma moving from volume-led generics to value plus innovation-led growth through strategic M&AsThe Indian pharmaceutical industry has shifted from volume-led generics to value plus innovation-led growth through strategic mergers and acquisitions over the past year, with 2025 deal activity reaching approximately 41 deals worth USD 2.7 billion in the first nine months. Major transactions included Torrent Pharmaceuticals acquiring a 46% controlling stake in JB Chemicals & Pharmaceuticals for USD 1.4 billion, Sun Pharmaceutical Industries acquiring Checkpoint Therapeutics for USD 355 million, and Zydus Lifesciences acquiring a majority stake in Amplitude Surgical for Euro 257 million. Experts predict M&A activity will accelerate in 2026, driven by platform acquisitions, biologics, and specialty segments.openPR.comSurgical Navigation System Market Set to Witness Significant Growth by 2025-2032|Amplitude Surgical SA, Brainlab AG, B. Braun Melsungen AG, Intersect ENTThe global surgical navigation system market is projected to grow from USD 8.33 billion in 2025 to USD 13.21 billion by 2032, representing a CAGR of 6.8% during this period. This growth is driven by rapid innovation and rising investments, highlighting significant opportunities for decision-makers in the industry. Companies and stakeholders are advised to strategically navigate the evolving market to capitalize on these upcoming opportunities.BusinessLineZydus’ Amplitude receives CE mark for its robotic surgical system ‘Andy’Amplitude Surgical announced that its proprietary robotic surgical system "Andy" has received CE mark approval, confirming compliance with European safety, performance, and quality standards for medical devices. The collaborative robot, developed through a strategic partnership with eCential Robotics, is designed to assist surgeons with precise bone resections during procedures, offering benefits including enhanced accuracy, reduced tissue trauma, smaller incisions, and faster patient recovery times. Zydus Lifesciences Ltd, the parent company of Amplitude Surgical following its acquisition earlier this year, highlighted that this milestone enables market entry across Europe and sets a new benchmark for robot-assisted orthopaedic procedures.Business StandardZydus PAT up 38% on strong India, US growth; board okays ₹5K cr fundraiseZydus Lifesciences, an Ahmedabad-headquartered pharmaceutical company, reported a 17% year-on-year rise in revenue to Rs 6,123 crore and a 38% increase in net profit to Rs 1,258.6 crore for the quarter, driven by strong performance in its US and India formulations businesses. The company's board approved raising up to Rs 5,000 crore through various equity instruments, subject to shareholder and regulatory approvals. During the quarter, Zydus completed its 100% acquisition of France-based Amplitude Surgical and made its first international wellness acquisition by purchasing UK-based Comfort Click Limited.Business Wire BlogZydus Announces Completion of the Acquisition of an 85.6% Stake in Amplitude Surgical and Upcoming Filing of a Simplified Tender OfferZydus completed its acquisition of an 85.6% stake in Amplitude Surgical on July 29, 2025, paying €6.25 per share for a total of €256.8 million. The company will file a simplified tender offer for remaining shares on July 30, 2025, at the same price, aiming to secure over 90% of voting rights.Ortho Spine NewsAmplitude Surgical – Consolidated annual revenue of €110.8 million, up +5.7% at constant exchange rates – Ortho Spine NewsAmplitude Surgical reported consolidated annual revenue of €110.8 million for the 2024-25 fiscal year, representing a 5.7% increase at constant exchange rates compared to the previous year. The company experienced growth in both its domestic French market (+4.8%) and international operations (+8.2%), although total revenue slightly fell short of earlier outlooks due to unfavorable exchange rate effects.YahooAmplitude Surgical – Consolidated annual revenue of €110.8 million, up +5.7% at constant exchange ratesAmplitude Surgical reported consolidated revenue of €110.8 million for fiscal year 2024-25, representing a 5.7% increase at constant exchange rates, slightly below its March 2025 outlook due to moderate fourth-quarter growth and unfavorable exchange rate effects, particularly in Australia. The company achieved 4.8% revenue growth in its home market of France (accounting for 73% of business) and 8.2% growth internationally at constant exchange rates, with direct business representing nearly 93% of total sales growing 6.0%. The company anticipates an EBITDA margin of approximately 27%, surpassing its projected 26.5% outlook.Business Wire BlogAmplitude Surgical – Consolidated annual revenue of €110.8 million, up +5.7% at constant exchange ratesAmplitude Surgical announced consolidated revenue of €110.8 million for fiscal year 2024-25, representing a 5.7% increase at constant exchange rates, with growth of 4.8% in France and 8.2% internationally. The company, a French leader in surgical technologies for lower limb orthopedics, also reported that Zydus MedTech (France) SAS completed a simplified tender offer for Amplitude Surgical shares on October 9, 2025. Based on unaudited financials, Amplitude Surgical anticipates an EBITDA margin of approximately 27% for the fiscal year ending June 30, 2025.